Sirona Biochem Corp. (SRBCF) Financials Nov 14, 20
Post# of 250674
Posted On: 11/17/2014 5:12:33 AM
Sirona Biochem Corp. (SRBCF) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sirona Biochem Corp.
Fiscal year is November-October. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 2,818 271,650 339,836 493,608 401,039
COGS excluding D&A 0 269,227 263,593 373,872 296,763
Depreciation & Amortization Expense 2,818 2,423 76,243 119,736 104,276
Depreciation 2,818 2,423 1,333 733 26,236
Amortization of Intangibles 0 0 74,910 119,003 78,040
Gross Income (2,818) (271,650) (339,836) (493,608) (401,039)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.22M 523,413 1.86M 2.53M 2.75M
Research & Development 732,639 373,847 799,721 441,304 968,314
Other SG&A 490,952 149,566 1.06M 2.09M 1.78M
Other Operating Expense 0 274,587 0 0 0
Unusual Expense 0 0 334,952 0 0
EBIT after Unusual Expense 0 0 (334,952) 0 0
Non Operating Income/Expense 0 0 13,622 4,405 235,604
Non-Operating Interest Income 10,638 - 15,005 1,837 156
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 10,532 1,052 78,533
Gross Interest Expense 0 0 10,532 1,052 78,533
Interest Capitalized 0 0 0 0 0
Pretax Income (1.22M) (1.07M) (2.51M) (3.02M) (2.99M)
Income Tax 0 0 (9,246) (31,975) (208,121)
Income Tax - Current Domestic 0 0 (9,246) (31,975) 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 77,320
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 285,441
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.22M) (1.07M) (2.51M) (2.98M) (2.78M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.22M) (1.07M) (2.51M) (2.98M) (2.78M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.22M) (1.07M) (2.51M) (2.98M) (2.78M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.22M) (1.07M) (2.51M) (2.98M) (2.78M)
EPS (Basic) (0.06) (0.04) (0.05) (0.04) (0.03)
Basic Shares Outstanding 21.96M 26.42M 54.09M 73.94M 92.29M
EPS (Diluted) (0.06) (0.04) (0.05) (0.04) (0.03)
Diluted Shares Outstanding 21.96M 26.42M 54.09M 73.94M 92.29M
EBITDA (1.22M) (1.07M) (2.12M) (2.9M) (3.05M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sirona Biochem Corp.
Fiscal year is November-October. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 2,818 271,650 339,836 493,608 401,039
COGS excluding D&A 0 269,227 263,593 373,872 296,763
Depreciation & Amortization Expense 2,818 2,423 76,243 119,736 104,276
Depreciation 2,818 2,423 1,333 733 26,236
Amortization of Intangibles 0 0 74,910 119,003 78,040
Gross Income (2,818) (271,650) (339,836) (493,608) (401,039)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.22M 523,413 1.86M 2.53M 2.75M
Research & Development 732,639 373,847 799,721 441,304 968,314
Other SG&A 490,952 149,566 1.06M 2.09M 1.78M
Other Operating Expense 0 274,587 0 0 0
Unusual Expense 0 0 334,952 0 0
EBIT after Unusual Expense 0 0 (334,952) 0 0
Non Operating Income/Expense 0 0 13,622 4,405 235,604
Non-Operating Interest Income 10,638 - 15,005 1,837 156
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 10,532 1,052 78,533
Gross Interest Expense 0 0 10,532 1,052 78,533
Interest Capitalized 0 0 0 0 0
Pretax Income (1.22M) (1.07M) (2.51M) (3.02M) (2.99M)
Income Tax 0 0 (9,246) (31,975) (208,121)
Income Tax - Current Domestic 0 0 (9,246) (31,975) 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 77,320
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 285,441
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.22M) (1.07M) (2.51M) (2.98M) (2.78M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.22M) (1.07M) (2.51M) (2.98M) (2.78M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.22M) (1.07M) (2.51M) (2.98M) (2.78M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.22M) (1.07M) (2.51M) (2.98M) (2.78M)
EPS (Basic) (0.06) (0.04) (0.05) (0.04) (0.03)
Basic Shares Outstanding 21.96M 26.42M 54.09M 73.94M 92.29M
EPS (Diluted) (0.06) (0.04) (0.05) (0.04) (0.03)
Diluted Shares Outstanding 21.96M 26.42M 54.09M 73.94M 92.29M
EBITDA (1.22M) (1.07M) (2.12M) (2.9M) (3.05M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)